Journals / Nöropsikiyatri Arşivi / 2015 / Cilt: 52 - Sayı: 2

Tekrarlayan İskemik İnme Karakteristikleri ve İkincil Korumadaki Yeterliliğin Değerlendirilmesi

Recurrent Ischemic Stroke Characteristics and Assessment of Sufficiency of Secondary Stroke Prevention

Pages
139–144
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A multidisciplinary outpatient model of stroke care may be beneficial for decreasing the incidence of RIS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Disabilities due to stroke lead to a serious individual and socioeconomic burden.
📊
Key Findings & Data:Methods: The records of patients with a diagnosis of ischemic stroke between November 2009 and November 2011 in our unit were retrospectively investigated.
💡
Conclusion & Impact:A multidisciplinary outpatient model of stroke care may be beneficial for decreasing the incidence of RIS.
🔬Design:Modeling & Simulation
📍Scope:2009 Verileri
⚙️Variables:Domain Parameters

Abstract

Introduction: Disabilities due to stroke lead to a serious individual and socioeconomic burden. In this presented hospital-based study, we aimed to evaluate recurrent ischemic stroke (RIS) characteristics and the sufficiency of secondary prevention regarding the most common modifiable risk factors. Methods: The records of patients with a diagnosis of ischemic stroke between November 2009 and November 2011 in our unit were retrospectively investigated. Results: Ninety-one (18%) out of 500 patients with ischemic stroke had RIS. Hypertension, diabetes mellitus, ischemic heart disease, hyperlipidemia, atrial fibrillation, and smoking were found in 88%, 43%, 36%, 30%, 11%, and 14% of the patients, respectively. Thirty-eight percent of the patients had more than two risk factors. While 14% of the hypertensive patients did not use antihypertensive medications, antihypertensive treatment was insufficient in 39% of those who already used antihypertensive medications. Twenty-three percent of the patients received no prophylactic agents. Sixty percent of the patients with a history of atrial fibrillation were on oral anticoagulant therapy (warfarin), and the international normalized ratio was <2.0 in 73% of them. Of the diabetic patients, 87% had an HgbA1C level above 6%. The LDL level was higher than 100 mg/dL in 72% of the patients. Conclusion: The incidence of RIS and risk factors in our retrospective study was compatible with the results of those in literature. Secondary prophylactic treatment and modification of risk factors in the stroke patients were not satisfactory. The improvement of the patients' adherence to treatment is also very important in addition to the optimal treatment and follow-up strategy for decreasing the incidence of RIS. A multidisciplinary outpatient model of stroke care may be beneficial for decreasing the incidence of RIS.

Özet

Amaç: İnmeye bağlı özürlülükler bireysel ve sosyo-ekonomik olarak ciddi yük oluşturmaktadır. Hastane temelli bu çalışmamızda tekrarlayan iskemik inme (Tİİ) karakteristikleri ve en sık gözlenen değiştirilebilir risk faktörleri bağlamında ikincil korumadaki yeterliliğin değerlendirilmesi amaçlanmıştır. Yöntem: Servisimizde Kasım 2009 ve Kasım 2011 yılları arasında iskemik inme tanısıyla yatırılan hastaların kayıtları retrospektif olarak incelendi. Bulgular: Beş yüz iskemik inmeli hastanın 91'inin (%18) Tİİ olduğu görüldü. Hastaların %85'inde hipertansiyon, %43'ünde diabet, %36'sında iskemik kalp hastalığı, %30'ünde hiperlipidemi, %11'inde atriyal fibrilasyon (AF), %14'ünde sigara kullanımı vardı. %38'i ikiden fazla risk faktörü taşımaktaydı. Hipertansif hastaların %14'ü antihipertansif kullanmazken, kullananların %39'unun tansiyon kontrolü yetersizdi. Tİİ öncesi hastaların %23'ü hiçbir profilaktik ajan almıyordu. AF'si olanların %60'ı oral antikoagülan tedavi (varfarin) kullanıyordu, kullananların %73'ünün INR değeri <2 idi. Diyabetik hastaların %87'sinin HgbA1C değeri 6'nın üzerinde idi. Hastaların %72'sinin LDL değeri 100 mg/dL'nin üzerinde idi. Sonuç: Çalışma sonuçlarımız literatürdeki Tİİ ve risk faktörleri sıklığı ile uyumlu bulunmuştur. Ancak ikincil koruma tedavisi ve risk faktörleri modifikasyonunda önemli ölçüde yetersizlikler olduğu görülmüştür. Tİİ sıklığını azaltmak için doğru tedavi ve takip rejimi belirleme yanında hasta uyumunu artırmanın da oldukça önemli olduğunu düşünmekteyiz. Multidisipliner inme polikliniği modeli Tİİ sıklığını azaltmak için faydalı olabilir.

🔖

Cite This Article

KOCAMAN, G., DÜRÜYEN, H., KOÇER, A., ASİL, T. (2015). Tekrarlayan İskemik İnme Karakteristikleri ve İkincil Korumadaki Yeterliliğin Değerlendirilmesi. Nöropsikiyatri Arşivi, Cilt: 52 - Sayı: 2, 139–144. https://ajindex.com/articles/292388

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU. Epidemiyology of ischemic stroke subtypes according to TOAST crite- ria:incidence, recurrence, and long-term survival in ischemic stroke subtype: a population-based study. Stroke 2001
  2. [CrossRef] Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Ischemic stroke subtypes: population-based study of functional outcome, sur- vival, and recurrence. Stroke 2000
  3. [CrossRef] Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Burvill PW, Anderson CS, Stewart-Wynnel EG. Long-term risk of first recurrent stroke in the Perth Community Stroke Study. Stroke 1998
  4. [CrossRef] Mohan KM, Crichton SL, Grieve AP, Rudd AG, Wolfe CD, Heuschmann PU. Frequency and predictors for the risk of stroke recurrence up to 10 years af- ter stroke: the South London Stroke Register. J Neurol Neurosurg Psychiatry 2009
  5. [CrossRef] Mohan KM, Wolfe CD, Rudd AG, Heuschmann PU, Kolominsky-Rabas PL, Grieve AP. Risk and cumulative risk of stroke recurrence: a systematic review and meta-analysis. Stroke 2011
  6. [CrossRef] Modrego PJ, Pina MA, Mar Fraj M, Llorens N. Type, causes, and prognosis of stroke recurrence in the province of Teruel, Spain. A 5-year analysis. Neurol Sci 2000
  7. [CrossRef] Filippi A, Bignamini AA, Sessa E, Samani F, Mazzaglia G. Secondary prevention of stroke in Italy. A Cross-sectional survey in family practice. Stroke 2003
  8. [CrossRef] Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke 1993
  9. [CrossRef] Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natu- ral history of clinically identifiable subtypes of cerebral infarction. Lancet 1991
  10. [CrossRef] Expert Panel on Detection, Evaluation, and Treatment of High Blood Choles- terol in Adults. Executive summary of the Third Report of the National Cho- lesterol Education Program (NCEP) Expert Panel in Adults (Adult Treatment Panel III). JAMA 2001
  11. [CrossRef] American Diabetes Association. Standards of medical care in diabetes- 2010. Diabetes Care 2010
  12. [CrossRef] Adams HP Jr, Davis PH, Leira EC, Chang KC, Bendixen BH, Clarke WR, Woolson RF, Hansen MD. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the T